The Memorandum of Association of Beximco Pharmaceuticals LTD Report provides a complete overview of the company’s memorandum since its inception.
1.1 Objective of the Study
The purpose of the report is to understand Memorandum and various particulars.
1.2 Scope of the report
❖ The report contains the company’s profile and data about the owners, senior executives, locations, subsidiaries, markets, products, and company history. ❖ The report explains the company’s memorandum and its various features. ❖ This report also gives an overview of its business and current position in the market.
2. Company Profile
Beximco Pharmaceuticals Ltd. is a leading edge pharmaceutical company. It is situated in Dhaka, Bangladesh. It is acclaimed for its outstanding product quality, well manufacturing facilities, and outstanding professional services. It was established in 1976 and started its production in 1980.The company was listed in the Dhaka Stock Exchange in 1986 and also listed in Chittagong Stock Exchange and AIM London Stock Exchange.
The board of directors:-
|A S F Rahman |Chairman | |Salman F Rhman |Vice Chairman | |Nazmul Hasan MP |Managing Director | |Iqbal Ahned |Director | |Mohammad Abul Qasem |Director | |Osman Kaiser Chowdhury |Director | |Abu Bakar Siddiqur Rahman |Director | |Advocate Ahsanul Karim |Director | |Dr. Abdul Alim Khan |Independent Director |
Md. Asad Ullah, FCS
|Osman Kaiser Chowdhury |Member of the Board of Directors | |Nazmul Hassan MP |Managing Director | |Rabbur Reza |Chief Operating Officer | |Ali Nawaz |Chief Financial Officer | |Afsar Uddin Ahmed |Director, Commercial |
Each of the company’s activity must benefit and add value to the common wealth of our society. The company is accountable to each of the constituents with whom it interacts such as employees, customers, business associates, fellow citizen. share-holders
The company’s capital is as follows:-
|Authorized Capital | 2000 million Tk | |Paid Up Capital | 1,259.57million Tk |
2.5 Research and Development (R & D)
Beximco Parma’s R&D team works meticulously towards creating generic formulations. Their dedication can be witnessed in their successful development of challenging formulations such as multi-layer tablets, CFC-free inhalers and sustained release formulations to name just a few.
Corporate Headquarters: 17 Dhanmondi R/A Road No: 2 Dhaka 1205, Bangladesh Operational Headquarters: 19 Dhanmondi R/A Road No: 7 Dhaka 1205, Bangladesh Factory: Auspara, Tongi, Gazipur.
The plant is situated near Dhaka. The company’s manufacturing site extends over an area of 23 acres.
3. Memorandum of Association